✦ LIBER ✦

Effects of Chronic Renal Failure on the Pharmacokinetics of Ruboxistaurin and its Active Metabolite 338522

✍ Scribed by Dr Stephen Wise, Eunice Yuen, Clark Chan, Yeo Kwee Poo, Lorraine Teng, Titus Lau, James Voelker

Book ID: 119926711
Publisher: Springer International Publishing AG
Year: 2006
Tongue: English
Weight: 117 KB
Volume: 45
Category: Article
ISSN: 0312-5963
DOI: 10.2165/00003088-200645030-00005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Delayed elimination of triamterene and i

Delayed elimination of triamterene and its active metabolite in chronic renal failure

✍ H. Knauf; W. Möhrke; E. Mutschler 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 401 KB

Effect of Severe Renal Failure and Haemo

Effect of Severe Renal Failure and Haemodialysis on the Pharmacokinetics of Levosimendan and Its Metabolites

✍ Dr Jaakko Puttonen, Sampo Kantete, Matti Kivikko, Sari Häkkinen, Veli-Pekka Harj 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 172 KB

The Effects of Calciferol and Its Metabo

The Effects of Calciferol and Its Metabolites on Patients With Chronic Renal Failure

✍ Voigts, Anne L. 📂 Article 📅 1983 🏛 American Medical Association 🌐 English ⚖ 567 KB

Pharmacokinetics of torasemide and its m

Pharmacokinetics of torasemide and its metabolites in healthy controls and in chronic renal failure

✍ H. Spahn; H. Knauf; E. Mutschler 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 344 KB

The pharmacokinetics of 20 mg torasemide i.v. has been studied in 7 healthy controls and 9 patients with varying degrees of renal impairment. Torasemide had a t1/2 of about 4h which was independent of kidney function, as the nonrenal clearance of torasemide was 3-times greater than its renal clearan

Differential consequences of renal failu

Differential consequences of renal failure on the pharmacokinetics of Oxprenolol and its main metabolite

✍ P. Dayer; Ph. Glasson; L. Balant; R. Striberni; J. Fabre 📂 Article 📅 1983 🏛 Springer-Verlag 🌐 English ⚖ 666 KB

Pharmacokinetics of oral diltiazem and f

Pharmacokinetics of oral diltiazem and five of its metabolites in patients with chronic renal failure

✍ Maha Tawashi; Julien Marc-aurèle; Daniel Bichet; Jean Spénard; Lyne Larivière; D 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 2 views

The pharmacokinetics of oral diltiazem were studied in 10 patients with chronic renal failure not requiring dialysis and in five healthy volunteers after a single dose of 120mg. We found that patients with chronic renal failure had lower amounts of unchanged diltiazem and of its main metabolite (MA)